These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 33859744)

  • 1. c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation.
    Tang YC; Hsiao JR; Jiang SS; Chang JY; Chu PY; Liu KJ; Fang HL; Lin LM; Chen HH; Huang YW; Chen YT; Tsai FY; Lin SF; Chuang YJ; Kuo CC
    Theranostics; 2021; 11(11):5232-5247. PubMed ID: 33859744
    [No Abstract]   [Full Text] [Related]  

  • 2. A positive feedback loop between PFKP and c-Myc drives head and neck squamous cell carcinoma progression.
    Liu W; Ding Z; Tao Y; Liu S; Jiang M; Yi F; Wang Z; Han Y; Zong H; Li D; Zhu Y; Xie Z; Sang S; Chen X; Miao M; Chen X; Lin W; Zhao Y; Zheng G; Zafereo M; Li G; Wu J; Zha X; Liu Y
    Mol Cancer; 2024 Jul; 23(1):141. PubMed ID: 38982480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity protein 1/microRNA-92b forms a feedback loop promoting the migration and invasion of head and neck squamous cell carcinoma.
    Pang P; Fang H; Wu H; Wang S; Liu M; Jin S; Qi Z; Li Z; Liu F; Sun C
    Bioengineered; 2021 Dec; 12(2):11397-11409. PubMed ID: 34905435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternatively spliced ANLN isoforms synergistically contribute to the progression of head and neck squamous cell carcinoma.
    Guo E; Mao X; Wang X; Guo L; An C; Zhang C; Song K; Wang G; Duan C; Zhang X; Yang X; Yuan Z; Sun J; Li X; Yang W; Meng H; Miao S
    Cell Death Dis; 2021 Aug; 12(8):764. PubMed ID: 34344861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transketolase in human Müller cells is critical to resist light stress through the pentose phosphate and NRF2 pathways.
    Chen Y; Zhang T; Zeng S; Xu R; Jin K; Coorey NJ; Wang Y; Wang K; Lee SR; Yam M; Zhu M; Chang A; Fan X; Zhang M; Du J; Gillies MC; Zhu L
    Redox Biol; 2022 Aug; 54():102379. PubMed ID: 35779441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PLEK2 promotes cancer stemness and tumorigenesis of head and neck squamous cell carcinoma via the c-Myc-mediated positive feedback loop.
    Zhao X; Shu D; Sun W; Si S; Ran W; Guo B; Cui L
    Cancer Commun (Lond); 2022 Oct; 42(10):987-1007. PubMed ID: 36002342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effects of ML385 on Head and Neck Squamous Cell Carcinoma: Implications for NRF2 Inhibition as a Therapeutic Strategy.
    Jeong EJ; Choi JJ; Lee SY; Kim YS
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNFAIP2 confers cisplatin resistance in head and neck squamous cell carcinoma via KEAP1/NRF2 signaling.
    Xu T; Yang Y; Chen Z; Wang J; Wang X; Zheng Y; Wang C; Wang Y; Zhu Z; Ding X; Zhou J; Li G; Zhang H; Zhang W; Wu Y; Song X
    J Exp Clin Cancer Res; 2023 Aug; 42(1):190. PubMed ID: 37525222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of CCT3 as a prognostic factor and correlates with cell survival and invasion of head and neck squamous cell carcinoma.
    Wang Y; Liu P; Zhang Z; Wang J; Cheng Z; Fan C
    Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34505628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ELOVL6 promotes the progression of head and neck squamous cell carcinoma via activating WNT/β-catenin pathway.
    Wang R; Liu X; Li X; Qian M; Yang X; Jiang Q; Wang Y; Liu H; Chen J; Wang X; Gong L
    Mol Carcinog; 2024 Jun; 63(6):1079-1091. PubMed ID: 38426809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The short isoform of PRLR suppresses the pentose phosphate pathway and nucleotide synthesis through the NEK9-Hippo axis in pancreatic cancer.
    Nie H; Huang PQ; Jiang SH; Yang Q; Hu LP; Yang XM; Li J; Wang YH; Li Q; Zhang YF; Zhu L; Zhang YL; Yu Y; Xiao GG; Sun YW; Ji J; Zhang ZG
    Theranostics; 2021; 11(8):3898-3915. PubMed ID: 33664869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TKTL1 Knockdown Impairs Hypoxia-Induced Glucose-6-phosphate Dehydrogenase and Glyceraldehyde-3-phosphate Dehydrogenase Overexpression.
    Baptista I; Karakitsou E; Cazier JB; Günther UL; Marin S; Cascante M
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ETV5 facilitates tumor progression in head-neck squamous cell carcinoma.
    Yu S; Ma Z; Chen T; Wang H; Yao Q; Li J; Cheng J
    Oral Dis; 2024 May; 30(4):2004-2017. PubMed ID: 37649213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose-6-phosphate dehydrogenase and transketolase: Key factors in breast cancer progression and therapy.
    Zhen X; Zhang M; Hao S; Sun J
    Biomed Pharmacother; 2024 Jul; 176():116935. PubMed ID: 38876050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant overexpression of transcription factor Forkhead box D1 predicts poor prognosis and promotes cancer progression in HNSCC.
    Li J; Yan T; Wu X; Ke X; Li X; Zhu Y; Yang J; Li Z
    BMC Cancer; 2021 Nov; 21(1):1205. PubMed ID: 34772357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lactate secreted by PKM2 upregulation promotes Galectin-9-mediated immunosuppression via inhibiting NF-κB pathway in HNSCC.
    Chang H; Xu Q; Li J; Li M; Zhang Z; Ma H; Yang X
    Cell Death Dis; 2021 Jul; 12(8):725. PubMed ID: 34290225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P4HA2 contributes to head and neck squamous cell carcinoma progression and EMT through PI3K/AKT signaling pathway.
    Wu YL; Liu W; Zhao T; Jin J
    Med Oncol; 2024 May; 41(6):163. PubMed ID: 38777998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transketolase (TKT) activity and nuclear localization promote hepatocellular carcinoma in a metabolic and a non-metabolic manner.
    Qin Z; Xiang C; Zhong F; Liu Y; Dong Q; Li K; Shi W; Ding C; Qin L; He F
    J Exp Clin Cancer Res; 2019 Apr; 38(1):154. PubMed ID: 30971297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of deubiquitinating enzyme PSMD14 overcomes chemoresistance in head and neck squamous cell carcinoma by antagonizing E2F1/Akt/SOX2-mediated stemness.
    Jing C; Duan Y; Zhou M; Yue K; Zhuo S; Li X; Liu D; Ye B; Lai Q; Li L; Yao X; Wei H; Zhang W; Wu Y; Wang X
    Theranostics; 2021; 11(6):2655-2669. PubMed ID: 33456565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma.
    Osman AA; Arslan E; Bartels M; Michikawa C; Lindemann A; Tomczak K; Yu W; Sandulache V; Ma W; Shen L; Wang J; Singh AK; Frederick MJ; Spencer ND; Kovacs J; Heffernan T; Symmans WF; Rai K; Myers JN
    Clin Cancer Res; 2023 Apr; 29(7):1344-1359. PubMed ID: 36689560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.